The Welsh Analytical Prescribing Support Unit (WAPSU) has produced reports on a number of topics.
The following are available here:
This paper is intended to inform AWMSG of progress made in monitoring the usage of medicines appraised by AWMSG and the National Institute for Health and Care Excellence (NICE).
Monitoring Usage in Wales of Medicines Appraised by NICE and AWMSG - Data to March 2016
Monitoring Usage in Wales of Medicines Appraised by NICE and AWMSG - Data to March 2015
Monitoring Usage in Wales of Medicines Appraised by NICE and AWMSG - Data to March 2014
Monitoring of Medicines Appraised by NICE and AWMSG: Summary - Data to March 2013
Monitoring of Medicines Appraised by NICE and AWMSG - Data to September 2012
This document has been prepared by the Welsh Analytical Prescribing Support Unit (WAPSU) to provide a detailed analysis of diabetes therapeutic area prescribing at national, health board and GP cluster level. The report also incorporates GP cluster level comparators, a novel way of presenting prescribing data, which allows prescribing leads in GP clusters and health boards to benchmark prescribing data against the most similar GP clusters in terms of specific disease prevalence and socio-economic factors.
Primary Care Prescribing Analysis - Medicines Used in Diabetes (September 2015)
This paper provides an analysis of primary care prescribing in Wales and England for
medicines and preparations within the respiratory therapeutic area for the period July
2013–June 2014. The report contains information specific to Wales and its health
boards, and also data for England and North East (NE) England for comparative
Respiratory Prescribing Analysis with Cluster Level Comparators (2015)
This report outlines a proposed method for the development of cluster group
comparators, based on socio-economic similarity and disease prevalence, to enable
benchmarking of prescribing. The respiratory therapeutic area is used here to illustrate
the method, due to the impact of respiratory illness on the population, the high cost of
prescribing respiratory items, recent changes in the evidence base and the potential for
GP Cluster Level Comparators (2014)
These educational resource materials aim to support the appropriate prescribing of tramadol in NHS Wales by providing key healthcare professionals with resource materials to review the prescribing of tramadol within the complex context of pain management.
The materials have been developed with regard to promoting the appropriate use of tramadol and raising awareness of the risks associated with the misuse and diversion of supplies of tramadol.
The educational resource pack includes an introduction, audit materials for primary care, secondary care and overdose admissions through emergency departments, an educational slide set, WeMeReC bulletins, a patient information leaflet and a shared decision-making toolkit. The resources can be adapted locally and Word (or PowerPoint) versions of the documents can be requested from AWTTC.
Audit Materials (2013) (Updated 2014)
Educational Slide Set (2013) (Updated 2014)
WeMeReC Maps (2013)
WeMeReC Things to Know (2013)
Patient Information Leaflet (2013)
Shared Decision-Making Toolkit (2013)
This document reviews the prescribing of gluten-free products in Wales, with reference to the All Wales Guide to Prescribing Gluten-free Products.
Primary Care Prescribing Analysis 2012-2013 Gluten-free Products (2013)